Lifestyle Capacity Assessment Question 3: Can I realistically maintain these behaviors during off-medication periods
In clinical trials, people taking Ozempic lost an average of 2-3% of their body weight, while those taking Mounjaro lost an average of 3-4% of their body weight
Key distinctions between these agents include: Receptor breadth : Retatrutide's inclusion of GCGR agonism is unique among agents in advanced clinical development Hepatic effects : The glucagon component is under investigation for potential benefit in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD)
adults may be using a GLP-1 medication for weight loss, prevention, or chronic disease management
therefore, stick to the dosing pattern prescribed by the doctor to avoid inadvertent adverse effects of dose change 4
Most participants on 8 mg and 12 mg reached major weight loss milestones, including at least 1015% weight loss